WorldHeart to Present at Canaccord Adams Cardiovascular Conference
More News related to WHRT
- WorldHeart Signs Agreements for Next-Generation Minimally Invasive Blood Pump
- WorldHeart to Present at Canaccord Adams Cardiovascular Conference
- World Heart (WHRT) Announces IRB Approves Ventricular Assist Device BTT Study
- WorldHeart Receives IRB Approval at First Center in the Levacor(TM) VAD BTT Clinical Trial
- WorldHeart (WHRT) Appoints John Alexander Martin as President/CEO
More News related to Press Releases
- Minister Prentice Welcomes Olympic Torch to Quebec
- Go-Ped Pro-Ped: The Only Cali Legal, 100% Green, Stand-Up Gas Scooter
- Cavan Announces Management and Board Changes
- Cavan Announces Management and Board Changes
- The Government of Canada Achieves Critical Milestone in Chemicals Management Plan
SALT LAKE CITY, Nov. 5 /PRNewswire-FirstCall/ -- WorldHeart Corporation (Nasdaq: WHRT) today announced that J. Alex Martin, President and Chief Executive Officer, is scheduled to make an investor presentation and provide a company update at the Canaccord Adams Cardiovascular Conference at 2:00 p.m. EST on Tuesday, November 10, 2009. The conference will be held at the Nikko Hotel in San Francisco, California.
A live webcast of the Company's presentation at the conference will be available via a link provided at www.worldheart.com.
About WorldHeart Corporation:
WorldHeart is a developer of mechanical circulatory support systems headquartered in Salt Lake City, Utah with additional facilities in Oakland, California, USA and Herkenbosch, The Netherlands. WorldHeart's registered office is in Ottawa, Ontario, Canada.
SOURCE WorldHeart Corporation
Related Categories
Press ReleasesStocks Mentioned
-0.10Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
